(Q35234253)

7 August 2017

0 references

AMPK: A metabolic checkpoint that regulates the growth of EGFR activated glioblastomas (English)

1 reference

7 August 2017

2

Timothy F Cloughesy

1 reference

7 August 2017

Deliang Guo

1

1 reference

7 August 2017

Caius G Radu

series ordinal

3

1 reference

7 August 2017

Paul S Mischel

series ordinal

4

1 reference

7 August 2017

language of work or name

1 reference

6 January 2010

1 reference

7 August 2017

number of pages

2

1 reference

based on heuristic

inferred from page(s)

published in

Cell Cycle

1 reference

7 August 2017

volume

9

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

211-212

1 reference

The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

Understanding the Warburg effect: the metabolic requirements of cell proliferation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

Therapeutic strategies for inhibiting oncogenic BRAF signaling

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

AMPK phosphorylation of raptor mediates a metabolic checkpoint

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

Regulation of endothelial cell cycle by laminar versus oscillatory flow: distinct modes of interactions of AMP-activated protein kinase and Akt pathways

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

On respiratory impairment in cancer cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

13 July 2018

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180897

13 July 2018

Identifiers

DOI

10.4161/CC.9.2.10540

1 reference

release_k4vpke2pjfahrjvganotnhofwm

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k4vpke2pjfahrjvganotnhofwm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

3180897

1 reference

7 August 2017

1 reference